VBCG
TMO icon

Valley Brook Capital Group’s Thermo Fisher Scientific TMO Stock Holding History

Valley Brook Capital Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.51M Sell
3,010
-70
-2% -$33.6K 0.86% 38
2026
Q1 		$1.51M Buy
3,080
+5
+0.2% +$2.71K 1.02% 28
2025
Q4 		$1.78M Sell
3,075
-70
-2% -$39.6K 1.18% 23
2025
Q3 		$1.53M Hold
3,145
– – 1.03% 25
2025
Q2 		$1.28M Sell
3,145
-230
-7% -$96.2K 0.95% 28
2025
Q1 		$1.68M Sell
3,375
-1,035
-23% -$561K 1.32% 22
2024
Q4 		$2.29M Sell
4,410
-475
-10% -$261K 1.71% 14
2024
Q3 		$3.02M Buy
4,885
+25
+0.5% +$14.8K 2.17% 11
2024
Q2 		$2.69M Buy
4,860
+100
+2% +$57.3K 2.1% 10
2024
Q1 		$2.77M Buy
4,760
+100
+2% +$56.1K 2.21% 10
2023
Q4 		$2.47M Buy
4,660
+150
+3% +$72.6K 2.15% 8
2023
Q3 		$2.28M Buy
4,510
+230
+5% +$123K 2.26% 8
2023
Q2 		$2.23M Sell
4,280
-60
-1% -$32.4K 2.06% 9
2023
Q1 		$2.5M Buy
4,340
+60
+1% +$33.8K 2.31% 9
2022
Q4 		$2.36M Buy
4,280
+35
+0.8% +$18.5K 2.26% 10
2022
Q3 		$2.15M Buy
4,245
+10
+0.2% +$5.6K 2.35% 9
2022
Q2 		$2.3M Sell
4,235
-10
-0.2% -$5.5K 2.37% 9
2022
Q1 		$2.51M Buy
4,245
+210
+5% +$121K 2.16% 11
2021
Q4 		$2.69M Buy
4,035
+20
+0.5% +$12.5K 2.32% 9
2021
Q3 		$2.29M Sell
4,015
-30
-0.7% -$16.5K 2.27% 11
2021
Q2 		$2.04M Buy
4,045
+330
+9% +$156K 1.94% 13
2021
Q1 		$1.7M Buy
3,715
+120
+3% +$57.3K 1.53% 14
2020
Q4 		$1.67M Buy
+3,595
New +$1.69M 1.66% 14

Other funds holding TMO

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Valley Brook Capital Group's TMO Position: Q2 2026 in Review

Valley Brook Capital Group reduced its Thermo Fisher Scientific (TMO) stake by 2.3% in Q2 2026, selling an estimated $33.6K and leaving 3,010 shares worth $1.51M. The position accounts for 0.86% of the portfolio, ranked #38.

Valley Brook Capital Group first reported a position in TMO in Q4 2020 and has held it in 23 quarters since. The position peaked at $3.02M in Q3 2024. 1,512 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Valley Brook Capital Group held 3,010 shares of Thermo Fisher Scientific worth $1.51M as of Q2 2026.
  • Valley Brook Capital Group sold 70 Thermo Fisher Scientific shares in Q2 2026, an estimated $33.6K.
  • Thermo Fisher Scientific made up 0.86% of Valley Brook Capital Group's portfolio in Q2 2026, its #38 holding.
  • Valley Brook Capital Group first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 23 quarters since.
  • Valley Brook Capital Group's Thermo Fisher Scientific position peaked at $3.02M in Q3 2024.
  • 1,512 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Valley Brook Capital Group's 13F filing for Q2 2026, filed 27 Jul 2026.